Reliability of pain intensity clamping using response-dependent thermal stimulation in healthy volunteers by Cruz-Almeida, Yenisel et al.
Cruz-Almeida et al. BMC Neuroscience  (2015) 16:21 
DOI 10.1186/s12868-015-0164-4METHODOLOGY ARTICLE Open AccessReliability of pain intensity clamping using
response-dependent thermal stimulation in
healthy volunteers
Yenisel Cruz-Almeida1,2,3,4,5,6*, Kelly M Naugle7, Charles J Vierck5, Roger B Fillingim1,3,6 and Joseph L Riley3,6Abstract
Background: Pain intensity clamping uses the REsponse-Dependent Stimulation (REDSTIM) methodology to
automatically adjust stimulus intensity to maintain a desired pain rating set-point which is continuously monitored
from a subject’s real-time pain ratings. REDSTIM blinds subjects regarding the pain intensity set-point, supporting its
use for assessing intervention efficacy. By maintaining the pain intensity at a constant level, a potential decrease in
pain sensitivity can be detected by an increase in thermode temperature (unknown to the subject) and not by pain
ratings alone. Further, previously described sensitizing and desensitizing trends within REDSTIM provide a novel
insight into human pain mechanisms overcoming limitations of conventional testing methods. The purpose of the
present study was to assess the test-retest reliability of pain intensity clamping using REDSTIM during three separate
sessions.
Methods: We used a method for testing changes in pain sensitivity of human subjects (REDSTIM) where the
stimulus temperature is modulated to clamp pain intensity near a desired set-point. Temperature serves as the
response variable and is used to infer pain sensitivity. Several measures were analyzed for reliability including
average temperature and area under the curve (AUC). Intraclass correlation coefficients were calculated for each
measure at pain rating set-points of 20/100 and 35/100.
Results: Sixteen healthy individuals (mean age = 21.6 ± 3.9) participated in three experiments two days apart at
both pain rating set-points. Most reliability coefficients were in the moderate to substantial range (r’s = 0.79 to 0.94)
except for the negative AUC (r = 0.52), but only at the 20/100 pain rating set-point.
Conclusions: The present study supports the test-retest reliability of pain intensity clamping using the REDSTIM
methodology while providing a novel tool to examine human pain modulatory mechanisms and overcoming
common shortcomings of conventional quantitative sensory testing methods.
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To date, the majority of experimental pain studies using
quantitative sensory testing (QST) methodology have re-
lied on very short duration stimuli, which do not vary in
intensity, but can be adjusted to different intensities per
trial (i.e., thermal pain, mechanical pressure). Other
QST procedures that allow for prolonged exposures may
have changes in stimulus intensity that are out of the* Correspondence: cryeni@ufl.edu
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Pain intensity clamping using the REsponse-Dependent
Stimulation (REDSTIM) methodology was recently in-
troduced as a new psychophysical approach to assess
pain sensitivity in human subjects using prolonged
thermal stimulation [1,2]. REDSTIM automatically ad-
justs stimulus intensity to maintain a desired pain rat-
ing set-point by continuously monitoring the subject’s
real-time pain ratings. REDSTIM allows the mainten-
ance of sustained but tolerable pain levels by varying
stimulus intensity, which permits long trials of con-
tinuous stimulation even in the most pain-sensitiveentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pain system with longer stimulation exposure times,
testing slowly responding pain modulatory mecha-
nisms. All REDSTIM stimuli are administered with
subjects blinded to stimulus parameters while avoiding
direct subject-experimenter interactions. REDSTIM also
overcomes the drawback of administering a predeter-
mined stimulus magnitude when the subject popula-
tions include individuals with vastly different pain
sensitivities. The REDSTIM paradigm significantly over-
comes important confounds in human pain experimenta-
tion, which are currently unavoidable with conventional
QST methods [3].
During prolonged sequences of REDSTIM, pain inten-
sity ratings oscillate around the desired set-point with
similar temperature oscillations [1,2]. Previous work re-
vealed that REDSTIM oscillations during ascending and
descending series of stimuli yielded highly significant bi-
directional sensitization and desensitization trends in
healthy individuals [1]. Once the pain ratings exceed the
set-point, the stimulator algorithm starts a descending
stimulus series (i.e., temperature decrease) which reveals
a sensitizing trend (i.e., continued increase in pain rat-
ings despite decreases in temperature). Conversely, once
the pain ratings go below the set-point, the algorithm
starts an increasing stimulus series (i.e., temperature in-
crease) revealing a desensitizing trend (i.e., continued de-
crease in pain ratings despite increases in temperature).
In previous work we have used the sensitizing/desensi-
tizing trend terminology because the pain ratings are
trending in the opposite direction of the stimulus
temperature. This is not to be confused with the defini-
tions of sensitization and desensitization, as we have also
shown that the average running temperature does not
change across REDSTIM trials, suggesting that individ-
uals do not experience prolonged sensitization or
desensitization [4]. Although the exact mechanisms
underlying these trend effects are not clear, previous
work has shown that a desensitizing trend effect can be
established robustly by a one-step decrease in thermal
stimulation, termed offset analgesia [5]. Additionally,
expectation-mediated mechanisms, such as those involved
in placebo and nocebo effects, may also contribute. Thus,
the patterns of these sensitizing and desensitizing trends
likely reflect modulation of somatosensory input, which
may provide novel insights into human pain mechanisms.
An important feature of an outcome measure, for both
research and clinical purposes, is its reliable reproduction
under the same conditions. A recent review points to the
considerable variability in reliability estimates of currently
used thermal QST measures with reliability coefficients
ranging from fair to excellent [3]. To date, there are a lim-
ited number of studies using REDSTIM methodology in
healthy [1,2,4] and diseased human subjects [6], with nostudies examining its psychometric properties including
reliability. Only when appropriate psychometric studies
including reliability are conducted on a measure, can it be
utilized as a behavioral marker to quantify therapeutic re-
sponse to treatment [7]. REDSTIM could be specifically
useful in drug trials where subject blinding to changes in
pain sensitivity are critical for the study’s internal validity.
Therefore, the present investigation was designed to
examine the test-retest reliability of the REDSTIM mea-
sures across three different days at two different pain rat-
ing set-points.
Results
Sixteen healthy individuals (9 females) ranging in age
from 20 to 35 years of age (mean = 21.6, SD = 3.9) partici-
pated in three different sessions two days apart. As previ-
ously reported [1], all subjects experienced temperature
oscillations during REDSTIM stimulation on all three days
(Figure 1 shows all subjects on day 2 of testing at the 35/
100 pain rating set-point). Across the three days, the aver-
age pain rating was not significantly different from the
preset pain ratings of 20 and 35 out 100 (Figure 2). To
assess the reliability of the REDSTIM measures, several
variables were extracted from the output during the 120-
second maintenance phase of stimulation. Results are
presented by the individual variables obtained from the
REDSTIM output.
Test-retest reliability
Intraclass correlation coefficients (ICC) for each of the
variables of interest across the three days of testing are
presented in Table 1. In summary, most variables de-
rived from the output had reliability coefficients in the
moderate to substantial range (r’s = 0.79 to 0.94) except
for the negative AUC (r = 0.52), but only at the 20/100
pain rating set-point. Figure 3 shows all scatterplots
across the three days of testing by each pain rating set-
point.
A repeated measures ANOVA was also performed to
compare the REDSTIM measures across days and eVAS
pain ratings (20 and 35). The assumptions of normality
and sphericity were met for all the variables examined.
Results are summarized in Table 2. There were no statis-
tically significant differences after correcting for multiple
comparisons.
Discussion
This is the first study designed to assess the test-retest
reliability of REDSTIM tested at the thenar eminence of
the palm over 120 seconds across three different days.
The reliability coefficients were in the moderate to
excellent range supporting its inter-session or test-retest
repeatability. The only REDSTIM measure that had
“fair” test-retest reliability occurred when using the
Figure 1 Measures obtained from the REDSTIM cycles.
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many participants getting down to 0/100 eVAS pain
ratings). Given the importance of assessing pain sensi-
tivity in a controlled and unbiased fashion for thera-
peutic efficacy trials, as well as the ability to measure
effects of prolonged painful stimulation on the noci-
ceptive system, REDSTIM has enormous potential for
advancing the current state of clinical pain research
and treatment. Self-report visual analog scales have
previously shown excellent psychometric properties
including reliability [8,9]. Quiton & Greenspan [4] also
found that the variability of pain ratings in response to
heat pain was stable within- and across- experimental
sessions with the greatest variability at lower pain
levels. However, previous studies have used conven-
tional QST methodology without the ability to blind
the participants, avoid direct subject-experimenter
interactions and the inability to continuously adjustFigure 2 Average pain ratings across the three days at set-points of 20/10thermode temperature from the real-time eVAS ratings of
the subjects like in this study’s REDSTIM methodology.
Although it can be seen from Figure 1 the large between-
subject variability in the temperature oscillations, these os-
cillations appear to be stable across three days.
The painful stimulation obtained with REDSTIM may
better model clinical pain conditions where the pain
experience remains at suprathreshold levels for extended
periods of time. A stimulus that lasts for a few seconds
may not reveal pain modulatory effects including
sensitization and desensitization. Traditional methods
of assessing sensitization have used short series of brief
thermal stimuli of constant magnitude while measuring
pain intensity changes [9,10]. These methods do not pro-
vide insight into slowly responding pain modulatory
mechanisms because the stimulation series is short in
order to keep the pain ratings from escalating to intoler-
able levels. The mechanisms underlying REDSTIM are0 (S-20) and 35/100 (s-35).
Table 1 Intraclass correlation coefficients along with the 95% confidence intervals for the measures derived from the
REDSTIM output across 3 different days of testing
eVAS = 20 Probability eVAS = 35 Probability
ICC (95%CI) ICC (95%CI)
Positive AUC 0.79 (0.51-0.92) p < 0.001 0.88 (0.71-0.96) p < 0.001
Negative AUC 0.52 (0.00-0.60) p = 0.041 0.80 (0.54-0.93) p < 0.001
Running Ave Temp: 60 sec 0.90 (0.76-0.96) p < 0.001 0.94 (0.85-0.98) p < 0.001
Running Ave Temp: 120 sec 0.89 (0.74-0.96) p < 0.001 0.92 (0.81-0.97) p < 0.001
Positive AUC = Mean area under the curve of positive half-cycles.
Negative AUC = Mean area under the curve of negative half-cycles.
Running Ave Temp: 60 sec = Mean temperature across first 60 seconds of trial.
Running Ave Temp: 120 sec = Mean temperature across entire 120 seconds of trial.
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REDSTIM also shows that even 2 minutes of very low
pain may not be enough to address sensitization and
desensitization [4]. Future studies elucidating the
underlying mechanisms involved in the REDSTIM
paradigm are needed including studies using higher
temperature set-points and longer stimulation periods.
However, the present study serves as a first step to ad-
dress the reproducibility of this method in clinical and
translational pain research.
There are several limitations in the present study that
should be taken into consideration. First, the degree to
which expectations impact the measures obtained from
REDSTIM is not known. Continuous pain ratings re-
quire an increased focus on pain compared to conven-
tional pain application, which may lead to a higher painFigure 3 Average temperature correlations across the three days by pain sperception than unattented pain application. However,
we provided standardized instructions to continuously
rate sensation magnitude. Therefore, the subjects were
not intentionally biased toward the ascending or de-
scending series of stimulation. Future studies should
be designed to examine whether sensitization and
desensitization trends have common mechanisms with
placebo and nocebo manipulations. Second, the current
findings are only relevant to heat stimuli and other stimuli
modalities may yield different findings. Third, the current
study tested only mild to moderate pain intensity set-
points, thus the stability of patterns at moderate to severe
pain intensity set-points is not known. Finally, the present
study was carried out in healthy young participants. It will
be important to examine the stability of the REDSTIM
paradigm in older individuals and those with clinical painet-point.
Table 2 Means and standard deviations for the measures
derived from the REDSTIM output across 3 different days
of testing
Day 1 Day 2 Day 3
(Mean ± SD) (Mean ± SD) (Mean ± SD)
Positive AUC
eVAS = 20 79.6 ± 55.2 59.4 ± 35.5 74.1 ± 41.0
eVAS = 35 79.5 ± 51.1 65.6 ± 33.9 65.3 ± 39.0
Negative AUC
eVAS = 20 86.8 ± 55.9 56.3 ± 36.2 62.9 ± 7.3
eVAS = 35 83.7 ± 52.5 61.8 ± 33.9 69.2 ± 41.5
Running Ave Temp:
60 sec (°C)
eVAS = 20 44.5 ± 2.6 45.4 ± 2.1 45.7 ± 2.3
eVAS = 35 45.9 ± 1.8 46.1 ± 1.7 46.4 ± 1.8
Running Ave Temp:
120 sec (°C)
eVAS = 20 44.9 ± 2.3 45.2 ± 1.8 45.5 ± 2.1
eVAS = 35 46.0 ± 1.7 45.9 ± 1.8 46.5 ± 1.9
Positive AUC = Mean area under the curve of positive half-cycles.
Negative AUC = Mean area under the curve of negative half-cycles.
Running Ave Temp: 60 sec = Mean temperature across first 60 seconds of trial.
Running Ave Temp: 120 sec = Mean temperature across entire 120 seconds
of trial.
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over time.
Conclusions
Despite its limitations, our study supports the repeatabil-
ity and stability of REDSTIM measures, which has im-
portant implications for clinical pain research studies.
The REDSTIM paradigm may provide new insights into
the mechanisms underlying chronic pain, which often
fluctuates at various intensity levels. Unlike conventional
methods, REDSTIM blinds the subject regarding the
pain intensity set-point, supporting the future use of
REDSTIM for assessing intervention efficacy. By main-
taining the pain intensity at a constant level with the
REDSTIM paradigm, a potential decrease in pain sensi-
tivity can be detected by an increase in thermode
temperature (unknown to the subject) and not by the
pain ratings alone. Finally, the prolonged stimulation in
REDSTIM may provide a novel insight into human pain
mechanisms while overcoming common shortcomings
of conventional QST methods.
Methods
Participants
Recruitment and study procedures were approved by the
University of Florida Institutional Review Board. Written
informed consent was obtained from all participants.
The volunteers were required to have (1) no significantspontaneous pain anywhere in the body; (2) no ongoing
pharmacotherapy with narcotics or antidepressants; (3)
no disease that might significantly affect pain perception
or unduly increase risk of injury (e.g., neurological disor-
ders, serious psychiatric disorders, diabetes, hyperten-
sion, serious cardiovascular disorders, and chronic pain).
Twelve of the sixteen participants were included in a
previous study [1].
Pain measurement
Experimental pain was measured with an electronic ver-
sion of a visual analog scale [11]. The electronic visual
analog scale (eVAS) consisted of a low-friction sliding
potentiometer of 100 mm travel. The left endpoint of
the scale was identified as “no pain”, while the right end-
point was defined as “intolerable pain”. There were no
divisions between these two anchors. The position of the
slider was electronically converted into a pain rating be-
tween 0 and 100%. The slider automatically returned to
the left (“no pain”) position when so required by the
protocol. The eVAS was mounted into the surface of a
small inclined desk positioned to facilitate precise op-
eration with minimal fatigue. The custom-built testing
system (Neuroanalytics Corporation, Gainesville, FL)
integrated all inputs (temperature process value, eVAS
signal) and outputs (stimulus temperature control, stimu-
lus timing) and allowed automated execution of test pro-
tocols with preprogrammed parameters, including limits
for temperature.
Response-Dependent Stimulation (REDSTIM) method
Thermal stimuli were administered with a flat copper
contact thermode of 23x23mm in size. The thermode
was electronically held at the desired temperature by a
Peltier thermoelectric device. It was brought into light
skin contact of reproducible force by solenoid activation,
which was preprogrammed in the stimulator control
software, allowing fully automated data collection. A
pain intensity set-point was defined, and an algorithm in
the stimulator control software calculated the deviation
of the patient’s actual pain rating from the set-point
as well as the derivative of this error. These data were
the basis for automatic adjustments of the stimulus
temperature to maintain an average pain rating that
equaled the set-point.
In summary, REDSTIM is composed of the induction
and the maintenance phase. During the induction phase,
the thermode temperature was increased from non-
painful levels (35°C) with temperature steps decreasing
in size as pain ratings approach the set-point. During
the induction phase, the temperature could increase
or stay the same, but never decrease. Once pain inten-
sity reached the set-point the maintenance phase
began. When pain intensity exceeded the set-point the
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pain intensity was below the set-point, the stimulus
temperature was stepped up. A temperature limit is set
to prevent thermal injury of subjects that are pain in-
sensitive. More detailed information on the system,
software and paradigm has been previously reported
elsewhere [1,2]. For the present study, continuous heat
application was used to examine the psychometric
properties of the oscillations occurring during the
REDSTIM methodology.
Testing protocol
Thermal stimulation was conducted during three separate
and identical daily sessions each separated by two-days
apart. During each session REDSTIM experiments were
conducted on the thenar eminence of the hand. Two
set-points were tested on each subject in every session:
20/100 and 35/100 pain ratings. REDSTIM oscillations
around the set-point were sampled every 1.5 seconds
for a period of 120 seconds during all sessions and at
both 20/100 and 35/100 set-point parameters. We used
mild to moderate pain rating set-points to avoid reach-
ing intolerable levels of pain in the most sensitive sub-
jects. All test conditions were the same for the three
experimental sessions and subjects were not informed
of the pain rating set-points used.
Pain ratings above the set-point progressed in positive
half-cycles that began within ascending temperature pro-
gressions, progressed to a high peak pain rating and then
returned to the set-point. Similarly, pain ratings below
the set-point in negative half-cycles began within de-
scending temperature progressions progressed to a low
peak pain rating and then returned to the set-point. For
each half-cycle (positive and negative), deviations from
the set-point were summed over time and the average
area under the curve (AUC) was calculated for each sub-
ject for each day of testing. In addition, the software pro-
gram automatically calculates the average temperature
as the cycle progresses. The output provides a running
average temperature needed to maintain the set-point at
60 seconds (i.e., for the first 60 seconds of the trial) and
at 120 seconds of the cycle (i.e., average of the entire
trial). Test-retest reliability was calculated for each of
these variables.
Data analysis
Measures must have at least “Fair” test-retest reliability
(ICC > 0.41) in order to be acceptable for its use, but
ideally coefficients should fall within the “Moderate”
(ICC > 0.61) to “Substantial” (ICC > 0.81) range [6,12].
Based on this premise, we estimated that a sample size
of 16 subjects was required to measure an intra-class
correlation coefficient (ICC) of at least 0.61 across three
days, with a power of at least 0.80 at an alpha level of0.05. We also assessed differences between days using a
repeated measures ANOVA with “Days” and “eVAS
set-point” (20 or 35) as within-subjects variables. First,
data were examined for distribution, presence of ex-
treme outliers and the Mauchly’s test of Sphericity was
performed. If the sphericity assumption was violated,
then Greenhouse-Geisser degrees of freedom correc-
tions were applied. In addition, Bonferroni was used to
adjust for multiple comparisons. Statistical analyses
were conducted with IBM SPSS 22 for Windows. For
all tests, 2-sided p values less than 0.05 were consid-
ered statistically significant.
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